Delivery of antigen using a novel mannosylated dendrimer potentiates immunogenicity in vitro and in vivo

Sheng, K, Kalkanidis, M, Pouniotis, D, Esparon, S, Tang, C, Apostolopoulos, V and Pietersz, G 2008, 'Delivery of antigen using a novel mannosylated dendrimer potentiates immunogenicity in vitro and in vivo', European Journal of Immunology, vol. 38, no. 2, pp. 424-436.


Document type: Journal Article
Collection: Journal Articles

Title Delivery of antigen using a novel mannosylated dendrimer potentiates immunogenicity in vitro and in vivo
Author(s) Sheng, K
Kalkanidis, M
Pouniotis, D
Esparon, S
Tang, C
Apostolopoulos, V
Pietersz, G
Year 2008
Journal name European Journal of Immunology
Volume number 38
Issue number 2
Start page 424
End page 436
Total pages 13
Publisher Wiley - VCH Verlag GmbH & Co. KGaA
Abstract Antigen mannosylation has been shown to be an effective approach to potentiate antigen immunogenicity, due to the enhanced antigen uptake and presentation by APC. To overcome disadvantages associated with conventional methods used to mannosylate antigens, we have developed a novel mannose-based antigen delivery system that utilizes a polyamidoamine (PAMAM) dendrimer. It is demonstrated that mannosylated dendrimer ovalbumin (MDO) is a potent immune inducer. With a strong binding avidity to DC, MDO potently induced OVA-specific Tcell response in vitro. It was found that the immunogenicity of MDO was due not only to enhanced antigen presentation, but also to induction of DC maturation. Mice immunized with MDO generated strong OVA-specific CD4-/CD8+ T cell and antibody responses. MDO also targeted lymph node DC to cross-present OVA, leading to OTI CD8+ T cell proliferation. Moreover, upon challenge with B16-OVA tumor cells, tumors in mice pre-immunized with MDO either did not grow or displayed a much more delayed onset, and had slower kinetics of growth than those of OVA-immunized mice. This mannose-based antigen delivery system was applied here for the first time to the immunization study. With several advantages and exceptional adjuvanticity, we propose mannosylated dendrimer as a potential vaccine carrier. © 2008 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.
DOI - identifier 10.1002/eji.200737578
ISSN 0014-2980
Versions
Version Filter Type
Citation counts: Scopus Citation Count Cited 90 times in Scopus Article | Citations
Altmetric details:
Access Statistics: 109 Abstract Views  -  Detailed Statistics
Created: Mon, 06 Dec 2010, 14:11:00 EST by Catalyst Administrator
© 2014 RMIT Research Repository • Powered by Fez SoftwareContact us